Ye Yi-qing
Title:
Associate chief pharmaceutist
Bio:
Education Background:
2016.06-2016.08 Changhai Hospital of Shanghai,Clinical pharmacist teacher training
2014.09-2015.09：The Children’sHospital,School ofMedicine, Zhejiang University, Clinical pharmacist training
2011.09-2012.02Department of Pharmacology and Pharmacy,the University of Hong Kong,Clinical Research Associate
2001.09-2004.12Zhejiang University,Master of pharmacology
1997-09-2001.06Zhejiang University,Bachelor of pharmacy
Expertise:
Medication for pregnant and lactating women
Research Interests:
1. Design and characterize novel polymer and peptide for nucleic acids delivery
2. Clinical pharmacology of Gynecology and Obstetrics
Research Narrative:
The main research direction is the drug new formulations and nano-targeted drug delivery systems.She has undertaken some projects, including the National Natural Science Foundation, Provincial Natural Science Foundation. The research results won the second prize and third prize of Zhejiang Science and Technology Progress Award, and the first prize of the Natural Science of the Ministry of Education.
Publication:
1. Li XY; Shen B; Chen Q; Zhang X; Ye Yiqing; Wang F; Zhang XM. Antitumor effects of cecropin B-LHRH' on drug-resistant ovarian and endometrial cancer cells[J]. 2016, 16(1): 251.
2. Ye Yi-Qing, Xu YY; Liang WL, Leung GPH, Cheung KH, Zheng CH, Lam JKW. Enhanced permeability of DNA-loaded chitosan oligosaccharide nanoparticles through Calu-3 cell layer. Journal of Drug Targeting,2013,21,474-486
3. Situ JQ, Ye Yi-Qing, Zhu XL, Yu RS, You J, Yuan H, Hu FQ, Du YZ. Specific targeting of A54 homing peptide functionalized dextran-g-poly(lactic-co-glycolicacid) micelles to tumor cells. International Journal of Nanomedicine,2015,10,665-675
4. Zhao Y, Zheng C, Zhang L, Chen Y, Ye Yi-Qing, Zhao M. Knockdown of STAT3 expression in SKOV3 cells by biodegradable siRNA-PLGA/CSO conjugate micelles, Colloids and Surfaces B: Biointerfaces, 2015,1(127):155-63.
5. Cai LL, Liu P, Li X, Huang X, Ye Yi-Qing, Chen FY, Yuan H, Hu FQ, Du YZ. RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells International Journal of Nanomedicine,2011, 6 ,3499-3508
6. Wu QA, Ye Yi-Qing＊. Neuromuscular blockade after therapy with magnesium sulfate and amlodipine. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2010，68(1), 225-231.
7. Ye Yi-Qing, Hu FQ, Du YZ, and Yu HY. Enhanced Cytotoxicity of Core modified Chitosan based Polymeric Micelles for Doxorubicin Delivery. Journal of Pharmaceutical Science, 2009,98(2): 704-712
8. Ye Yi-Qing, Yang FL, Hu FQ, Du YZ, Yuan H and Yu HY. Core-modified Chitosan based Polymeric Micelles for Controlled Release of Doxorubicin. International Journal of Pharmaceutics, 2008, 352 (2): 294-301
9. Hu FQ, Du YZ, Yuan H, Ye YQ and Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. International Journal of Pharmaceutics 2006 (314)83–89.
10. Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ and Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids and Surfaces B: Biointerfaces 2005 (45) 167–173
Email:
yqye@zju.edu.cn
